Equity
Share Repurchase Program - Amount Remaining
Royalty Pharma Share Repurchase Program - Amount Remaining decreased by 10.5% to $1.70B in Q1 2026 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ1 2016
Last reportedQ1 2026
Metric ID:
share_repurchase_program_amount_remainingHistorical Data
4 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $2.30B | $2.00B | $1.90B | $1.70B |
| QoQ Change | — | -13.0% | -5.0% | -10.5% |
| YoY Change | — | — | — | -26.1% |
Range$1.70B – $2.30B
Avg YoY Growth-26.1%
Median YoY Growth-26.1%
Current Streak3+ quarters decline
Share Repurchase Program - Amount Remaining at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's share repurchase program - amount remaining?
- Royalty Pharma (RPRX) reported share repurchase program - amount remaining of $1.70B in Q1 2026.